Suppr超能文献

葡萄膜黑色素瘤的综合死因:1530 例连续诊断患者的死亡率,直至死亡。

Comprehensive causes of death in uveal melanoma: mortality in 1530 consecutively diagnosed patients followed until death.

机构信息

Department of Clinical Neuroscience, Division of Eye and Vision, Karolinska Institutet, Stockholm, Sweden.

Ocular Oncology Service and St. Erik Ophthalmic Pathology Laboratory, St. Erik Eye Hospital, Stockholm, Sweden.

出版信息

JNCI Cancer Spectr. 2023 Oct 31;7(6). doi: 10.1093/jncics/pkad097.

Abstract

BACKGROUND

Uveal melanoma has a high propensity for metastatic spread. Yet, the comprehensive causes of death in a large consecutive cohort followed from diagnosis to death remain unknown.

METHODS

All Swedish patients diagnosed with melanoma involving the iris, choroid, and/or ciliary body after January 1, 1960, were assessed for this study. Sequential inclusion was halted upon encountering the first surviving patient during data collection. Causes of death were collected from the National Cause of Death Registry and audited by analysis of up to 15 causative diagnoses.

RESULTS

A total of 1530 patients were included, each histopathologically verified with primary uveal melanoma. Mortality from metastatic uveal melanoma was 31% at 5 years, 40% at 10 years, 45% at 20 years, 47% at 30 years, and 48% between 40 and 60 years post-diagnosis. Notably, the longest period between diagnosis and metastatic fatality was 49.6 years. Additionally, 186 other causes of death were recorded, with cardiovascular diseases constituting 26%, other cancers 10%, stroke 6%, dementias 2%, and lower respiratory infections 2% of total mortalities. Mortality from colorectal, lung, prostate, and stomach carcinomas over 60 years were 1.4%, 1.4%, 1.2%, and 0.9%, with metastatic uveal melanoma being the leading cumulative and annual cause of death for the initial 41 and 5 years post-diagnosis, respectively.

CONCLUSIONS

In this large consecutive cohort, half of the included patients ultimately succumbed to metastatic uveal melanoma, with deaths occurring up to 50 years after diagnosis. One-quarter and one-tenth of patients died from cardiovascular diseases and other cancers, respectively.

摘要

背景

葡萄膜黑色素瘤具有很高的转移扩散倾向。然而,从诊断到死亡,在一个大的连续队列中,导致死亡的综合原因尚不清楚。

方法

所有在 1960 年 1 月 1 日后被诊断为虹膜、脉络膜和/或睫状体黑色素瘤的瑞典患者都被纳入本研究。在数据收集过程中遇到第一个存活患者时,连续纳入就停止了。死因是从国家死因登记处收集的,并通过对多达 15 个病因诊断的分析进行审核。

结果

共纳入 1530 例患者,均经组织病理学证实为原发性葡萄膜黑色素瘤。转移性葡萄膜黑色素瘤的 5 年死亡率为 31%,10 年死亡率为 40%,20 年死亡率为 45%,30 年死亡率为 47%,40 至 60 年诊断后死亡率为 48%。值得注意的是,从诊断到转移性死亡的最长时间间隔为 49.6 年。此外,还记录了 186 例其他死因,心血管疾病占 26%,其他癌症占 10%,中风占 6%,痴呆占 2%,下呼吸道感染占 2%。60 岁以上结直肠癌、肺癌、前列腺癌和胃癌的死亡率分别为 1.4%、1.4%、1.2%和 0.9%,转移性葡萄膜黑色素瘤是诊断后前 41 年和 5 年的主要累积和年度死因。

结论

在这个大的连续队列中,一半的患者最终死于转移性葡萄膜黑色素瘤,死亡发生在诊断后 50 年。分别有四分之一和十分之一的患者死于心血管疾病和其他癌症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27f3/10724524/3f88325698dd/pkad097f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验